(Q43952265)

28 November 2017

Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania (English)

1 reference

28 November 2017

0 references

0 references

1 reference

9

1 reference

28 November 2017

14

Tanner M

1 reference

28 November 2017

Acosta CJ

1

1 reference

28 November 2017

Galindo CM

2

1 reference

28 November 2017

Schellenberg D

3

1 reference

28 November 2017

Aponte JJ

4

1 reference

28 November 2017

Kahigwa E

5

1 reference

28 November 2017

Urassa H

6

1 reference

28 November 2017

Schellenberg JR

7

1 reference

28 November 2017

Masanja H

8

1 reference

28 November 2017

Kitua AY

10

1 reference

28 November 2017

Lwilla F

11

1 reference

28 November 2017

Mshinda H

12

1 reference

28 November 2017

Menendez C

13

1 reference

28 November 2017

Alonso PL

15

1 reference

28 November 2017

1 May 1999

1 reference

Tropical Medicine and International Health

28 November 2017

1 reference

28 November 2017

4

1 reference

28 November 2017

368-376

1 reference

28 November 2017

5

1 reference

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

28 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00406.X

Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00406.X

Analysis of multiple Plasmodium falciparum infections in Tanzanian children during the phase III trial of the malaria vaccine SPf66.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00406.X

Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00406.X

Plasmodium falciparum malaria in the first year of life in an area of intense and perennial transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00406.X

Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00406.X

Safety in infants of SPf66, a synthetic malaria vaccine, delivered alongside the EPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00406.X

Absence of seasonal variation in malaria parasitaemia in an area of intense seasonal transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00406.X

SPf66, a chemically synthesized subunit malaria vaccine, is safe and immunogenic in Tanzanians exposed to intense malaria transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.1999.00406.X

10.1046/J.1365-3156.1999.00406.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference